Nautilus Biotechnology, Inc.
Data quality: 83%
NAUT
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$3.21
▲
$0.08
(2.56%)
Mkt Cap: 406.27 M
Price
$3.21
Mkt Cap
406.27 M
Day Range
$3.10 — $3.27
52-Week Range
$0.62 — $4.31
Volume
145,164
Open $3.12
50D / 200D Avg
$2.63
22.03% above
50D / 200D Avg
$1.59
102.06% above
Quick Summary
Key Takeaways
Negative free cash flow of -51.97 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-33.69%
Above sector avg (-53.47%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio14.95
Interest CoverageN/A
Valuation
PE (TTM)
-6.89
Below sector avg (-1.47)
P/B Ratio2.40
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.9 | -1.5 |
| P/B | 2.4 | 1.6 |
| ROE % | -33.7 | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
ETFs Holding This Stock
BRSIX
BRSIX
0.04% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -59.00 M |
| ROE | -33.69% | ROA | -28.50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -51.97 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 14.95 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 125.34 M | Tangible Book Value | 169.14 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6.89 | Forward P/E | N/A |
| P/B Ratio | 2.40 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -12.79% | ||
| Market Cap | 406.27 M | Enterprise Value | 382.40 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.47 | Revenue / Share | N/A |
| FCF / Share | -0.41 | OCF / Share | -0.40 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 88.09% |
| SBC-Adj. FCF | -60.53 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -59.00 M | -70.78 M | -63.68 M | -57.92 M | -523,083.0 |
| EPS (Diluted) | -0.47 | -0.56 | -0.51 | -0.46 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | -576,035.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 41.11 M | 50.48 M | 47.25 M | 37.67 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 191.11 M | 242.74 M | 305.57 M | 350.05 M | 150.86 M |
| Total Liabilities | 34.14 M | 34.01 M | 40.21 M | 35.13 M | 5.62 M |
| Shareholders' Equity | 156.97 M | 208.73 M | 265.35 M | 314.92 M | 5.00 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 12.39 M | 27.65 M | 19.40 M | 114.52 M | — |
| Current Assets | 105.96 M | 132.83 M | 176.84 M | 187.21 M | 1.30 M |
| Current Liabilities | 7.95 M | 7.63 M | 9.12 M | 6.79 M | 388,507.0 |
{"event":"ticker_viewed","properties":{"ticker":"NAUT","listing_kind":"stock","pathname":"/stocks/naut","exchange":"Nasdaq","country":"US"}}